Reported Earlier, Avidity Biosciences Prices $400.9M Public Offering Of 10.55M Common Shares At $38/Share
Reported Earlier, Avidity Biosciences Prices $400.9M Public Offering Of 10.55M Common Shares At $38/Share
如早前報道的那樣，avidity biosciences以每股38美元的價格定價了價值4.009億美元的1055萬股普通股的公開發行。
All of the shares to be sold in the offering are to be sold by Avidity. The gross proceeds to Avidity from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $400.9 million. The offering is expected to close on or about June 17, 2024, subject to the satisfaction of customary closing conditions
所有股份的銷售均由奧威迪公司銷售。在扣除包銷折扣、佣金和其他發售費用之前，預計奧威迪公司從本次交易中獲得的總收益將達4.009億美元，本次發售預計將於2024年6月17日左右結束，須符合習慣的交割條件
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。